Cargando…

Validation of a routine two‐sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD

Endogenous markers of kidney function are insensitive to early declines in glomerular filtration rate (GFR) and in rodent models, validated, practical alternatives are unavailable. In this study, we determined GFR by modeling the plasma clearance of two compounds, iohexol and inulin, and compared th...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Mandy E., Laverty, Kimberly J., Jeronimo, Paul S., Kaufmann, Martin, Jones, Glenville, White, Christine A., Holden, Rachel M., Adams, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430119/
https://www.ncbi.nlm.nih.gov/pubmed/28483858
http://dx.doi.org/10.14814/phy2.13205
_version_ 1783236165560696832
author Turner, Mandy E.
Laverty, Kimberly J.
Jeronimo, Paul S.
Kaufmann, Martin
Jones, Glenville
White, Christine A.
Holden, Rachel M.
Adams, Michael A.
author_facet Turner, Mandy E.
Laverty, Kimberly J.
Jeronimo, Paul S.
Kaufmann, Martin
Jones, Glenville
White, Christine A.
Holden, Rachel M.
Adams, Michael A.
author_sort Turner, Mandy E.
collection PubMed
description Endogenous markers of kidney function are insensitive to early declines in glomerular filtration rate (GFR) and in rodent models, validated, practical alternatives are unavailable. In this study, we determined GFR by modeling the plasma clearance of two compounds, iohexol and inulin, and compared the findings to common endogenous markers. All plasma clearance methods of both iohexol and inulin detected a decline in renal function weeks prior to any increase in endogenous marker. Iohexol plasma clearance and inulin plasma clearance had a very high agreement and minimal bias when using 12‐sample models. However, only iohexol could be accurately simplified to a two‐sample, one‐compartment estimation strategy. Following an IV injection of low‐dose iohexol and two timed blood samples at 30 and 90 min, one can accurately approximate a complex 12‐sample strategy of plasma clearance. This method is simple enough to use in routine, longitudinal analysis of larger cohort animal studies.
format Online
Article
Text
id pubmed-5430119
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-54301192017-05-17 Validation of a routine two‐sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD Turner, Mandy E. Laverty, Kimberly J. Jeronimo, Paul S. Kaufmann, Martin Jones, Glenville White, Christine A. Holden, Rachel M. Adams, Michael A. Physiol Rep Original Research Endogenous markers of kidney function are insensitive to early declines in glomerular filtration rate (GFR) and in rodent models, validated, practical alternatives are unavailable. In this study, we determined GFR by modeling the plasma clearance of two compounds, iohexol and inulin, and compared the findings to common endogenous markers. All plasma clearance methods of both iohexol and inulin detected a decline in renal function weeks prior to any increase in endogenous marker. Iohexol plasma clearance and inulin plasma clearance had a very high agreement and minimal bias when using 12‐sample models. However, only iohexol could be accurately simplified to a two‐sample, one‐compartment estimation strategy. Following an IV injection of low‐dose iohexol and two timed blood samples at 30 and 90 min, one can accurately approximate a complex 12‐sample strategy of plasma clearance. This method is simple enough to use in routine, longitudinal analysis of larger cohort animal studies. John Wiley and Sons Inc. 2017-05-08 /pmc/articles/PMC5430119/ /pubmed/28483858 http://dx.doi.org/10.14814/phy2.13205 Text en © 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Turner, Mandy E.
Laverty, Kimberly J.
Jeronimo, Paul S.
Kaufmann, Martin
Jones, Glenville
White, Christine A.
Holden, Rachel M.
Adams, Michael A.
Validation of a routine two‐sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD
title Validation of a routine two‐sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD
title_full Validation of a routine two‐sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD
title_fullStr Validation of a routine two‐sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD
title_full_unstemmed Validation of a routine two‐sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD
title_short Validation of a routine two‐sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD
title_sort validation of a routine two‐sample iohexol plasma clearance assessment of gfr and an evaluation of common endogenous markers in a rat model of ckd
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430119/
https://www.ncbi.nlm.nih.gov/pubmed/28483858
http://dx.doi.org/10.14814/phy2.13205
work_keys_str_mv AT turnermandye validationofaroutinetwosampleiohexolplasmaclearanceassessmentofgfrandanevaluationofcommonendogenousmarkersinaratmodelofckd
AT lavertykimberlyj validationofaroutinetwosampleiohexolplasmaclearanceassessmentofgfrandanevaluationofcommonendogenousmarkersinaratmodelofckd
AT jeronimopauls validationofaroutinetwosampleiohexolplasmaclearanceassessmentofgfrandanevaluationofcommonendogenousmarkersinaratmodelofckd
AT kaufmannmartin validationofaroutinetwosampleiohexolplasmaclearanceassessmentofgfrandanevaluationofcommonendogenousmarkersinaratmodelofckd
AT jonesglenville validationofaroutinetwosampleiohexolplasmaclearanceassessmentofgfrandanevaluationofcommonendogenousmarkersinaratmodelofckd
AT whitechristinea validationofaroutinetwosampleiohexolplasmaclearanceassessmentofgfrandanevaluationofcommonendogenousmarkersinaratmodelofckd
AT holdenrachelm validationofaroutinetwosampleiohexolplasmaclearanceassessmentofgfrandanevaluationofcommonendogenousmarkersinaratmodelofckd
AT adamsmichaela validationofaroutinetwosampleiohexolplasmaclearanceassessmentofgfrandanevaluationofcommonendogenousmarkersinaratmodelofckd